Skadden has advised Theravance Biopharma. Kirkland & Ellis and Matheson have advised Zymeworks. Theravance Biopharma, Inc. and Zymeworks Inc. have entered into a definitive agreement under...
Zymeworks to Acquire Theravance Biopharma in $929 Million Transaction
Intel to Repurchase 49% Stake in Fab 34 Joint Venture from Apollo
Goldman Sachs & Co. has advised Intel, with Skadden, Arps, Slate, Meagher & Flom LLP as legal counsel, and Eversheds Sutherland and PricewaterhouseCoopers LLP as tax...
Theravance Biopharma Sells Remaining Trelegy Royalties to GSK for $225 Million
Skadden is advising Theravance Biopharma, Inc. on the transaction. Theravance Biopharma, Inc. has entered into a definitive agreement to sell its remaining royalty interest in net...
Platform Science’s Acquisition of Trimble’s Global Transportation Telematics Business Units
Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel to Trimble, Gibson, Dunn & Crutcher LLP, Fenwick & West LLP and Fish &...
Intel and Apollo’s Joint Venture Related to Intel’s Fab 34 in Ireland
Skadden and Eversheds Sutherland served as legal counsel to Intel. Paul, Weiss, Rifkind, Wharton & Garrison served as legal counsel to the Apollo-managed funds and affiliates,...
Hewlett Packard Enterprise’s Acquisition of Juniper Networks
Wachtell, Lipton, Rosen & Katz, Covington & Burling and Freshfields Bruckhaus Deringer advised Hewlett Packard Enterprise, while Skadden advised Juniper Networks on the deal. Hewlett Packard...
GI Partners’ Investment in BusPatrol
Skadden and Osler, Hoskin & Harcourt advised BusPatrol, while Ropes & Gray advised GI Partners in the transaction. BusPatrol announced a significant growth investment from GI Data Infrastructure....
Ouster’s Merger With Velodyne
Barclays served as financial advisor and Latham & Watkins served as legal advisor to Ouster. BofA Securities, Inc. served as financial advisor and Skadden, Arps, Slate,...
Royalty Pharma’s Acquisition of Theravance Respiratory Company
Skadden advised Theravance Biopharma, while Goodwin Procter advised Royalty Pharma on the deal. Willkie Farr & Gallagher advised Innoviva on the sale of its stake in...
Intel’s $5.4 Billion Acquisition of Tower Semiconductor
Skadden, Arps, Slate, Meagher & Flom LLP and Yigal Arnon & Co. advised Intel, while Latham & Watkins, LLP and FISCHER (FBC & Co.) advised Tower...
Starry’s Business Combination with FirstMark Horizon Acquisition Corp.
Skadden, Arps, Slate, Meagher & Flom represented FirstMark Horizon Acquisition Corp., while Latham & Watkins represented Starry in the transaction. FirstMark Horizon Acquisition Corp. (“FirstMark”), a...